|
|
Dottikon ES Holding AG is a Switzerland-based holding company that specializes in hazardous chemistry and focuses on the exclusive synthesis of fine chemicals for the pharmaceutical and chemical industries. Its product range includes active pharmaceutical ingredients (APIs) and pharmaceutical intermediates, as well as industrial chemicals. Its pharmaceutical products can be found in medications for, among others, heart disease, asthma, high blood pressure and ulcers. Dottikon ES Holding AG's industrial end products include food additives, cosmetics, electro-chemicals, photo-chemicals and agricultural chemicals. The Company also offers distillation plants and thin layer evaporators for the recycling of solvents, as well as high temperature incinerators for the waste treatment of hazardous waste. As of March 31, 2012, the Company had two wholly owned subsidiaries: DOTTIKON EXCLUSIVE SYNTHESIS AG and DOTTIKON ES MANAGEMENT AG. It also held a 33.9%-stake in SYSTAG, System Technik AG. |
|
|
| 2019 | 2020 | Delta | | CHF (in Million) | % | CHF (in Million) | % | | Chemicals | 147.71 | 100% | 174.77 | 100% | +18.32% |
|
|
|
| 2019 | 2020 | Delta | | CHF (in Million) | % | CHF (in Million) | % | | Switzerland | 147.71 | 100% | 174.77 | 100% | +18.32% |
|
|
|
| Vote  | Quantity | Free-Float | Company-owned shares | Total Float |
| Stock A |
1 |
1,272,644 |
268,859 |
21.1% |
22,488 |
1.8% |
21.1% |
|
| Company contact information |
|
Dottikon Es Holding AG Hembrunnstrasse 17 Dottikon, Aargau (Argovia) 5605 Phone : +41.56.616.81.11 Fax : +41.56.616.89.45 Web : http://www.dottikon.com |
|
|
Sector Specialty & Advanced Pharmaceuticals
| | 1st jan. | Capitalization (M$) |
 |
 | DOTTIKON ES HOLDING AG | 157.58% | 2 106 |
| | | |
|
 | MERCK KGAA | 22.64% | 67 521 |
 | ZHANGZHOU PIENTZEHUANG PHARMACEUTICAL., LTD | 93.16% | 19 782 |
 | KYOWA KIRIN CO., LTD. | 9.13% | 14 477 |
| BETTA PHARMACEUTICALS CO., LTD. | 38.66% | 5 960 |
 | YUHAN CORPORATION | 35.94% | 3 707 |
 | RECIPHARM AB (PUBL) | 19.76% | 1 849 |
 | INDIVIOR | 222.05% | 1 272 |
 | SUPERNUS PHARMACEUTICALS, INC. | -10.08% | 1 117 |
| KISSEI PHARMACEUTICAL CO., LTD. | -32.85% | 937 |
| CALLIDITAS THERAPEUTICS AB (PUBL) | 83.36% | 809 |
| DONG-A ST CO., LTD. | -26.39% | 673 |
| NICHI-IKO PHARMACEUTICAL CO., LTD. | -26.01% | 623 |
 | KNIGHT THERAPEUTICS INC. | -29.82% | 531 |
| CHONG KUN DANG HOLDINGS CORP. | 1.49% | 469 |
 | MAYNE PHARMA GROUP LIMITED | -18.39% | 438 |
| THERAPEUTICSMD, INC. | -44.63% | 397 |
 | SCI PHARMTECH, INC. | 13.76% | 350 |
| CORMEDIX INC. | 8.93% | 255 |
| ASSEMBLY BIOSCIENCES, INC. | -73.02% | 182 |
| THERATECHNOLOGIES INC. | -27.70% | 182 |
|
Canada
Deutschland
France
Schweiz (DE)
United Kingdom
Report
